INTT inTest Corporation Q4 2025 EPS outperforms consensus estimates shares rise 674 percent on positive investor reaction MDLN Medline sharp Q4 2025 EPS miss triggers investor selloff pushing shares down 318 today Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia NCVA Virtus releases quarterly preferred share results with no unexpected shifts to planned cumulative distribution payouts International Business Machines Corp IBM Strategic Project QuiltWorks Partnership Bolsters LongTerm AI Cybersecurity Market Position